Valuation Stories

Should I rely on EZCORP management in December 2020?

  
As many millenniums are trying to avoid financial services space, it makes sense to focus on EZCORP Inc a little further and try to understand its current market patterns. We will evaluate why we are still confident in anticipation of a recovery. Is the firm valuation justified? Here we go over EZCORP Inc perspective on valuation to give you a better outlook on taking a positi... [more]
EZCORP Inc currently holds 464.44 M in liabilities with Debt to Equity (D/E) ratio of 0.68, which is about average as compared to similar companies. The entity has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EZCORP has an asset utilization ratio of 88.51 percent. This indicates that the company is making $0.89 for each dollar of assets. An increasing asset utilization means that EZCORP Inc is more efficient with each dollar of assets it utilizes for everyday operations.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;;'>FI</div>
  3 days ago at Macroaxis 
By Vlad Skutelnik
As many millenniums are trying to avoid energy space, it makes sense to concentrate on FTS International a little further and try to understand its current market patterns. We will evaluate why we are still confident in anticipation of a recovery. Is FTS International valuation justified? Here we go over the firm perspective on valuation to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#347AFC;color: #ffffff;font-size:0.9em;;'>RMR</div>
  3 days ago at Macroaxis 
By Raphi Shpitalnik
While some of us are excited about real estate space, it makes sense to sum up The RMR Group in greater detail to make a better assessment of its actual value. What exactly are RMR shareholders getting in December? Is the firm operations in 2020 sustainable? Here we are going to cover RMR Group perspective on valuation to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;;'>AP</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
While some of us are excited about healthcare space, it makes sense to concentrate on Aurinia Pharmaceuticals in greater detail to make a better assessment of its actual value. We are going to cover the possibilities of making Aurinia Pharmaceuticals into your portfolio. Is the entity valuation justified? Here I will cover 2020 perspective on the current valuation of the stock to give you a better outlook on taking a possible position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#169D0B;color: #E6E6FA;font-size:1.1em;;'>MB</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
As many of us are excited about healthcare space, it is fair to outline Meridian Bioscience. Why are we still confident in anticipation of a complete recovery. Is Meridian Bioscience valuation justified? Here I will cover 2020 perspective on the current valuation of the entity to give you a better outlook on taking a possible position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;;'>CE</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
As many millenniums are excited about industrials space, it is only fair to focus on CVD Equipment. We will evaluate why we are still confident in anticipation of a recovery. Is the firm valuation justified? Here I will cover 2020 perspective on the current valuation of CVD Equipment to give you a better outlook on taking a possible position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#169D0B;color: #E6E6FA;font-size:0.9em;;'>KMD</div>
  over a week ago at Macroaxis 
By Ellen Johnson
As many baby boomers are still indifferent towards healthcare space, it makes sense to go over Kamada. We will evaluate why we are still confident in anticipation of a recovery. Is the firm valuation justified? Here I will cover 2020 perspective on the current valuation of Kamada to give you a better outlook on taking a possible position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#3b5998;color: #F0F8FF;font-size:1.1em;;'>PS</div>
  over two weeks ago at Macroaxis 
By Achuva Shats
As many millenniums are excited about healthcare space, it is only fair to go over The Providence Service. We will evaluate why we are still confident in anticipation of a recovery. Is The Providence Service valuation sustainable? Here I will cover a perspective on valuation of Providence to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;;'>MI</div>
  over two weeks ago at Macroaxis 
By Achuva Shats
As many investors are getting excited about consumer cyclical space, it is fair to sum up Marriott International. We will analyze why Marriott International investors may still consider a stake in the business. What is the entity valuation so far in 2020? We are going to cover the stock perspective on valuation to give investors a better transparency on taking a position in it.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#82ADFD;color: #ffffff;font-size:0.9em;;'>MCS</div>
  over two weeks ago at Macroaxis 
By Raphi Shpitalnik
As many millenniums are excited about communication services space, it is only fair to sum up Marcus. We will analyze why it could be a much better year for Marcus shareholders. Is the firm valuation justified? Here we go over Marcus perspective on valuation to give you a better outlook on taking a position in this stock.